Clinical Trials Logo

Family Relations clinical trials

View clinical trials related to Family Relations.

Filter by:
  • Not yet recruiting  
  • Page 1

NCT ID: NCT06275412 Not yet recruiting - Type 1 Diabetes Clinical Trials

Family Intervention for Black Teens With Type 1 Diabetes

3Ms
Start date: June 2024
Phase: N/A
Study type: Interventional

The purpose of this study is to conduct a multicenter, randomized effectiveness trial of The 3Ms 2.0 compared to an educational control condition for improving adolescent glycemic control and diabetes-related family relationships and reducing primary caregiver diabetes-related distress among Black adolescents with type 1 diabetes (T1D) and their primary caregivers. The proposed study would develop and test The 3Ms 2.0 adapted intervention when delivered using a mobile health approach (accessed via parents' cell phone). The intervention will also include new family intervention content (videoclips and text messages).

NCT ID: NCT05965648 Not yet recruiting - Clinical trials for Autism Spectrum Disorder

Development of a Family-Based Transition Planning Program for Culturally-Diverse Youth on the Autism Spectrum

Start date: July 2023
Phase: N/A
Study type: Interventional

The goal of this clinical study is to develop a community-based program to support family members of transition-aged youth on the autism spectrum to help them plan for the future. The main aims of the study are: 1. To develop the Families FORWARD program 2. To conduct proof-of-concept testing of the Families FORWARD program Participants will complete surveys before and after participating in the program and will participate in exit interviews at the end of the program.

NCT ID: NCT05477901 Not yet recruiting - Inflammation Clinical Trials

Impacts of Cash Transfers on Child Neurodevelopment (Auxilio Brasil)

Start date: June 1, 2024
Phase: N/A
Study type: Interventional

This study examines the impact of Auxilio Brasil (AB), a cash transfer program to mothers of school-age children, on resource-deprived populations in Brazil and its protective effects on child neurodevelopment and mental health. The investigators will conduct a randomized clinical trial (RCT) among those already receiving AB in which 300 families will be randomized in a 1:1 ratio to receive either a high ($40/month) or low ($2/month) supplemental transfer for 2 years. Three hundred children (index child participants; 7-10 years old) will be enrolled across both study arms. Additionally, up to 150 siblings ("sibling participants;" 7-10 years old) will be enrolled. Eligible families who decide to participate will sign a study-specific informed consent (mother) and assent (child) form. The UNIFESP team will conduct the respective assessments at baseline, approximately 8- and 16- months, 24-months and approximately 6-months post-RCT. Aim 1: Determine the impact of high vs low cash transfers on children's exposure to adversities (ACEs) and neurodevelopment. Aim 2: Determine the impact of cash transfers on children's inflammatory markers and HPA activity/cortisol. Exploratory Aim: The investigators will explore (i) whether sex/gender of the children moderates the pathways in the above mediation model; and (ii) whether cash transfer-related effects persist 6 months post-RCT.